Use of palivizumab is underestimated in the Swedish Prescribed Drug Register – implications for register-based drug studies

Use of palivizumab is underestimated in the Swedish Prescribed Drug Register – implications for register-based drug studies

Marie Linder,1 Camilla Byström,1 Helle Kieler,1 Gunnar Bergman,2 Ann Haerskjold3,4 1Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden; 2Stockholm-Uppsala Department of Pediatric Cardiology, Astrid Lindgren Children's Hospital,...

Full description

Bibliographic Details
Main Authors: Linder M, Byström C, Kieler H, Bergman G, Haerskjold A
Format: Article
Language:English
Published: Dove Medical Press 2014-12-01
Series:Clinical Epidemiology
Online Access:http://www.dovepress.com/use-of-palivizumab-is-underestimated-in-the-swedish-prescribed-drug-re-peer-reviewed-article-CLEP

Internet

http://www.dovepress.com/use-of-palivizumab-is-underestimated-in-the-swedish-prescribed-drug-re-peer-reviewed-article-CLEP

Similar Items